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Abstract
Background: With improvements in genotyping technologies, genome-wide association studies
with hundreds of thousands of SNPs allow the identification of candidate genetic loci for
multifactorial diseases in different populations. However, genotyping errors caused by genotyping
platforms or genotype calling algorithms may lead to inflation of false associations between markers
and phenotypes. In addition, the number of SNPs available for genome-wide association studies in
the Japanese population has been investigated using only 45 samples in the HapMap project, which
could lead to an inaccurate estimation of the number of SNPs with low minor allele frequencies.
We genotyped 400 Japanese samples in order to estimate the number of SNPs available for
genome-wide association studies in the Japanese population and to examine the performance of
the current SNP Array 6.0 platform and the genotype calling algorithm "Birdseed".
Results: About 20% of the 909,622 SNP markers on the array were revealed to be monomorphic
in the Japanese population. Consequently, 661,599 SNPs were available for genome-wide
association studies in the Japanese population, after excluding the poorly behaving SNPs. The
Birdseed algorithm accurately determined the genotype calls of each sample with a high overall call
rate of over 99.5% and a high concordance rate of over 99.8% using more than 48 samples after
removing low-quality samples by adjusting QC criteria.
Conclusion: Our results confirmed that the SNP Array 6.0 platform reached the level reported
by the manufacturer, and thus genome-wide association studies using the SNP Array 6.0 platform
have considerable potential to identify candidate susceptibility or resistance genetic factors for
multifactorial diseases in the Japanese population, as well as in other populations.
Background
Together with technology developments on large-scale
single nucleotide polymorphism (SNP) genotyping [1,2],
there have been a number of genome-wide association
studies (GWAS) to identify candidate susceptibility or
resistance genetic factors for multifactorial diseases [3-7].
It is estimated that eleven million SNPs with a greater than
1% minor allele frequency (MAF) are located in the
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human genome [8]. Over six million SNPs have been
uploaded on public SNP databases through the Human
Genome Project and international SNP discovery projects.
Among these SNPs, over 900 K SNPs across the human
genome are selected with an average MAF of 19.6%,
18.2% and 20.6% in the HapMap Caucasians, Asians and
Africans, respectively, and can be simultaneously geno-
typed using Affymetrix Genome-Wide Human SNP Array
6.0 platform [9]. Several studies have evaluated the cover-
age of commercial platforms using HapMap population
data and genotype data of non-reference Caucasian popu-
lations [10-12]. Results from these studies indicated that
in a non-reference Caucasian population, as well as the
HapMap populations, commercial SNP typing platforms
offered similar levels of genome coverage. However, the
number of genotyped Japanese individuals in the Hap-
Map project was only 45 samples, which may lead to inac-
curate estimation of the number of SNPs with low MAF in
the Japanese population.
The SNP Array 6.0 platform offers the genotype calling
algorithm "Birdseed" to determine the genotypes of
909,622 SNPs [9]. The Birdseed algorithm performs a
multiple-chip analysis to estimate signal intensity for each
allele of each SNP, fitting probe-specific effects to increase
precision, and then makes genotype calls by fitting a
Gaussian mixture model in the two-dimensional A-signal
vs. B-signal space, using SNP-specific models to improve
accuracy. There was a report that 45% of SNPs observed to
be significantly associated with the disease did not agree
with Hardy-Weinberg equilibrium (HWE) using the previ-
ous version of Mapping 500 K Array set [13]. Some of the
miss-called SNPs would be induced by genotype calling
algorithms and are likely to be ranked as significantly
associated with the disease (false-positive). Therefore,
there are strong demands for accurate genotype calls using
the Birdseed algorithm.
The SNP Array 6.0 platform has three check points prior
to hybridization on GeneChip arrays in order to exclude
experimental errors; PCR amplicon size check by electro-
pherograms, DNase I digested fragment size check by elec-
tropherograms and quantity check of the purified PCR
products. The platform also includes Quality Control
(QC) probes for 3,022 SNPs to assess the overall quality
for a sample based on the Dynamic Model (DM) algo-
rithm. There are assay criteria to exclude experimental
errors and low-quality samples; however, we empirically
know that some samples, which pass these criteria, have
low-quality genotyping results.
In this study, we genotyped 400 non-HapMap Japanese
samples using the SNP Array 6.0 platform in order to eval-
uate the number of SNPs available for GWAS in the Japa-
nese population, to examine an appropriate approach for
acquiring accurate genotype calls using the Birdseed gen-
otype calling algorithm, and to evaluate the assay criteria
for preventing low-quality genotyping data.
Results
Genotyping 400 Japanese samples using SNP Array 6.0 
platform
We collected 2 sets of 200 Japanese samples for genotyp-
ing using the SNP Array 6.0 platform. The average concen-
tration of genomic DNA for the 1st set of 200 samples was
54.8 ng/μl and that for the 2nd set of 200 samples was 52.7
ng/μl. One of the critical points for the SNP Array 6.0 plat-
form to acquire high quality genotyping data is to prepare
a uniform quantity of 250 ng genomic DNA for Nsp I and
Sty  I  digestion steps. When an almost 10-fold excess
amount of genomic DNA was used, the average overall
call rate drastically decreased to about 80% for both Nsp
I and Sty I digestion steps with the Mapping 500 K Array
(data not shown).
The average concentration of purified PCR products for
the two sets of 200 samples was 524.4 ng/μl (range 412.8
to 718.0 ng/μl) and 497.3 ng/μl (range 256.6 to 939.8 ng/
μl), respectively (Figure 1a and Figure 2a). In total, 11
samples (2 samples for the 1st set and 9 samples for the 2nd
set) showed low QC call rates below the default 86% QC
criteria (Figure 1b and Figure 2b). The genotype calls of
909, 622 SNPs for each individual were determined using
the Birdseed genotype calling algorithm, embedded in the
Affymetrix Genotyping Console 2.0 software (Affyme-
trix). The 198 samples of the 1st set that were over 86% QC
criteria were used to assign genotypes and had an average
overall call rate of 99.58%, ranging from 96.42 to 99.90%
(Figure 1c). For the 2nd set, 191 samples were over 86%
QC criteria and the average overall call rate was 97.54%,
ranging from 89.52 to 99.27% (Figure 2c). When geno-
type calls were determined for every 48 samples analyzed
simultaneously in the same batch, the average overall call
rate was improved to 99.71% (range, 98.37 to 99.94%)
for the 1st set, and 98.66% (range, 94.86 to 99.76%) for
the 2nd set (Figure 1d and Figure 2d).
Assay criteria for experimental errors occurring on running 
batches
The SNP Array 6.0 platform has three check points prior
to hybridization on GeneChip arrays in order to remove
samples with experimental errors. However, some sam-
ples that pass these check points still have relatively low-
quality genotyping results with lower overall call rates
than 97%; 1 sample for the 1st set of 200 samples and 59
samples for the 2nd set of 200 samples. When genotype
calls were determined for every 48 samples simultane-
ously analyzed in the same batch, the average overall call
rate of 48 samples for batch #1 from the 2nd set was
97.21%, which was almost 2% lower than other batchesBMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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(Figure 2d). The concentration of purified PCR products
from batch #1 drastically fluctuated among the 48 sam-
ples (Figure 2a). The CV (standard deviation/average) of
the purified PCR product concentration for batch #1 was
much higher than that for any other batches from the two
sets of 200 samples (Figure 3). The CV of the purified PCR
product concentration is a new indicator to assess experi-
mental quality for each of the running batches, and may
remove the experimental errors occurring on the running
batches prior to hybridization on the GeneChip arrays.
For the 48 samples from batch #1 of the 2nd set, the intact
genomic DNA could not be detected clearly when the
samples were electrophoresed on 1.0% agarose gels (Fig-
ure 4). Therefore, these genomic DNAs for batch #1 of the
2nd set may have degraded due to repetitive freezing and
thawing, which led to low-quality genotyping results.
Preparation of the exact amount of intact genomic DNA is
considered to be one of the crucial points for the SNP
array 6.0 platform.
In order to assess the performance of the SNP Array 6.0
platform and the Birdseed algorithm, we mainly used gen-
otyping data obtained from the 1st set of 200 samples
because the 2nd set contained samples in poor condition.
Genotype calling accuracy with "Birdseed" algorithm
The genotype calling accuracy of the Birdseed algorithm
was considered to be improved as the sample number for
determining genotype calls increased. We determined
909,622 genotype calls for 12 samples among 198 sam-
ples with over 86% QC criteria, and used these genotype
calls as a reference. We also determined the genotype calls
of the same 12 samples under 6 different sample sizes,
Genotyping results of the 1st set of 200 samples using the SNP Array 6.0 platform Figure 1
Genotyping results of the 1st set of 200 samples using the SNP Array 6.0 platform. Colours are based on every 48 
samples analyzed simultaneously as a batch. a. Concentration of purified PCR products for each sample. b. QC call rate for 
each sample. c. Overall call rate for each sample, as determined by the Birdseed algorithm using total 198 samples that passed 
the default 86% QC criteria. d. Overall call rate for each sample, as determined by the Birdseed algorithm using samples in the 
same batch.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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using 12 samples, 24 samples, 36 samples, 48 samples, 72
samples and 96 samples. To investigate the genotype call-
ing accuracy of the Birdseed algorithm, we compared the
genotype calls determined under 6 different sample sizes
to the reference genotype calls for each of the 12 samples.
We prepared 4 sets of 12 samples from a batch of 48 sam-
ples (Batch #3) and performed the genotype call compar-
ison for each set of 12 samples. Figure 5 shows the average
overall call rate and the average concordance rate for each
set of the 12 samples. The average overall call rate for 4
sets of the 12 samples, which were determined with 12
samples, 24 samples, 36 samples, 48 samples, 72 samples,
96 samples and 198 samples, were 99.84%, 99.86%,
99.84%, 99.83%, 99.79%, 99.75% and 99.71%, respec-
tively. The average concordance rate for the 4 sets of the 12
samples under 6 different sample sizes were 99.47%,
99.75%, 99.80%, 99.84%, 99.86% and 99.87%, respec-
tively. Here, "No Calls" was excluded from the concord-
ance calculation.
Our results showed that the average overall call rate of the
12 samples was almost constant when the genotype calls
were determined with fewer than 48 samples; however, it
gradually decreased as the sample number increased from
48 to 198, which showed a negative correlation with a P
value of 0.0053. In contrast, the concordance rate gradu-
ally increased as the sample number increased, which
showed a positive correlation with a P value of 0.0115.
Removing low-quality samples by adjusting QC criteria
Our results showed that the average overall call rate grad-
ually decreased as the sample number increased, presum-
ably due to low-quality samples included in the genotype
calling with the Birdseed algorithm. Indeed, there was one
sample which had an overall call rate lower than 97%
among the 198 samples with over 86% QC call rate.
Therefore, we applied more stringent QC criteria to
remove the low-quality samples, because a linear relation-
ship was observed between QC call rate and overall call
Genotyping results of 2nd set of 200 samples using the SNP Array 6.0 platform Figure 2
Genotyping results of 2nd set of 200 samples using the SNP Array 6.0 platform. a. Concentration of purified PCR 
products for each sample. b. QC call rate for each sample. c. Overall call rate for each sample, as determined by the Birdseed 
algorithm using a total of 191 samples that passed the default 86% QC criteria. d. Overall call rate for each sample, as deter-
mined by the Birdseed algorithm using samples in the same batch.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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rate (Figure 6a). When we applied 95% QC criteria, 189
samples passed the QC criteria and the average overall call
rate improved from 99.58 to 99.65%. By comparing the
overall call rate determined under the 95% QC criteria
with that under the default criteria, 187 of 189 samples
improved by an average of 0.018% in overall call rate;
however, the remaining two samples showed decreased
overall call rate (by 0.76% and 0.12%) (Figure 6b). These
two samples were considered as outliers on the genotype
calling with the Birdseed algorithm and had to be
removed. We repeated the removal of samples until none
had a lower overall call rate than that determined under
the default criteria. A total of 184 samples had an overall
call rate that improved over the one determined under the
default criteria, with an average change of 0.035%. The
average overall call rate for the 184 samples was 99.71%,
which was 0.13% higher than the default QC criteria (Fig-
ure 6c).
Number of SNPs available for GWAS in the Japanese 
population
The genotype calls of 909,622 SNPs were determined with
184 samples after sample filtering with adjusted QC crite-
ria. However, these genotype calls still included inaccurate
SNPs, which could lead to inflation of false positives, pre-
sumably due to systematically miss-called SNPs. There-
fore, SNP filtering was considered to be important for a
reliable and accurate set of genotype calls that avoid false
association signals and false negative signals, allowing
rapid identification of disease susceptibility genetic fac-
tors. We reported that the poorly behaving SNPs were
effectively eliminated with the SNP filtering parameters;
MAF > 5% or 1%, HWE p-value > 0.001 and SNP call rate
> 95% [14]. Here, SNP call rate was defined for each SNP
as the number of successfully genotyped samples divided
by the number of total samples genotyped.
Among a total of 909,622 SNPs genotyped using 184 sam-
ples, 590,248 SNPs passed the three SNP filtering criteria
with MAF > 5%, HWE p-value > 0.001 and SNP call rate >
95%, while 661,559 SNPs passed with MAF > 1%, HWE
p-value > 0.001, and SNP call rate > 95%. A total of
180,859 SNPs were observed to be monomorphic in the
Japanese population.
Discussion
The emerging SNP typing technologies have enabled
genome-wide association studies to be conducted with
hundreds of thousands of genotyped SNPs. According to
Affymetrix, the SNP Array 6.0 platform can genotype over
Assay criteria for experimental errors occurring on running batches Figure 3
Assay criteria for experimental errors occurring on running batches. The CV of purified PCR product concentration 
is determined for each running batch. Overall call rate for each sample was determined by the Birdseed algorithm using sam-
ples in the same batch.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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900 K SNP markers across the human genome with an
overall call rate of at least 97%, over 99.7% concordant
with the HapMap genotypes, and the Mendelian inherit-
ance consistency for 10 Trios of greater than 99.9% when
performing analysis under the default 86% QC criteria. To
evaluate the SNP 6.0 Array platform and the Birdseed gen-
otype calling algorithm, we genotyped two sets of 200
non-HapMap Japanese samples using the SNP Array 6.0
platform.
When we applied the default 86% QC criteria, 2 samples
out of the 1st set of 200 samples were excluded and the
average overall call rate was 99.58%. There was one sam-
ple with an overall call rate of lower than 97% among the
198 samples. Here, we found a linear relationship
between QC call rate and overall call rate. Therefore, we
applied stringent QC criteria of over 95% in order to
remove the low-quality samples and found that the aver-
age overall call rate for 189 samples passing the stringent
QC criteria improved to 99.65%. Among the 189 samples,
187 samples had higher overall call rates than those deter-
mined under the default QC criteria; however, the remain-
ing two samples showed lower overall call rates (by 0.76%
and 0.12%). When we repeated the removal of samples
until none had a lower overall call rate than the one deter-
mined under the default criteria, none of the remaining
184 samples with an overall call rate lower than 97%. The
average overall call rate of 184 samples was thus improved
to 99.71%. The decay of average overall call rate may be
caused by some samples that pass the QC criteria, but still
have a low overall call rate. We can thus improve overall
call rate by removing these samples and adjusting the QC
criteria.
One of the crucial points for the SNP array 6.0 platform is
to prepare the exact amount of intact genomic DNA. A 10-
fold excess amount of genomic DNA decreased the overall
call rate of each sample to by about 80% and another
study revealed that samples with less than 50 ng/μl
genomic DNA show low overall call rates [15]. Therefore,
we checked the concentration and condition of genomic
DNA with the NanoDrop quatitation and agarose gel elec-
trophoresis. The SNP array 6.0 platform has three check
points to assess experimental errors prior to hybridization
on GeneChip arrays. Here, we found that the CV of the
purified PCR product concentration was another critical
indicator prior to hybridization in assessing the perform-
ance of each running batches. We suggest that samples
with a CV value over 0.15 are excluded from the remain-
der of the assay.
The genotype calling accuracy of the Birdseed algorithm
was assessed by comparing the 909,622 genotype calls of
12 samples from among198 samples with over 86% QC
criteria, to those of 12 samples determined with six differ-
ent sample sizes; 12 samples, 24 samples, 36 samples, 48
samples, 72 samples and 96 samples. The concordance
rate gradually increased as the number of samples
increased. The average concordance rate was almost con-
stant over 99.8%, when the genotype calls were deter-
mined with over 48 samples using the Birdseed algorithm.
However, the average overall call rate of the 12 samples
gradually decreased as the sample number increased from
48 to 198. We could explain the reasons why the overall
call rate decreases, and why the concordance rate increases
for these 12 samples in a grouping of samples greater than
48 by means of characteristic properties of the Birdseed
algorithm and minor allele frequency of each SNP. When
the sample number was smaller than 48, all of three clus-
ters designating AA, AB and BB genotypes were rarely
observed for the SNPs with low MAF. In such cases, the
Birdseed algorithm would determine the genotype as a
single cluster, however, would ambiguously genotype as
AA, BB and AB (tend to miss-genotype). Therefore, high
call rate and low concordance were observed with the
sample number smaller than 48. In contrast, when the
sample number was greater than 48, two or three clusters
would be observed for many SNPs. For these SNPs, the
Birdseed algorithm could determine the outlying samples
from each cluster as "No Calls", leading to low call rate
and high concordance.
We can accurately determine the genotype calls with high
overall call rates by determining the genotype calls with
more than 48 samples, after removing low-quality sam-
ples by adjusting the QC criteria. Our results showed that
the SNP Array 6.0 platform reached the expected level
reported by the manufacturer, with an average overall call
rate of over 99.5% and an average concordance rate of
Agarose gel electrophoresis pattern showing genomic DNA  from batch #1 of the 2nd set (lanes 1–8) and batch #2 of the  2nd set (lanes 1–8) and batch #2 of the 2nd set (lanes 9–16) Figure 4
Agarose gel electrophoresis pattern showing 
genomic DNA from batch #1 of the 2nd set (lanes 1–
8) and batch #2 of the 2nd set (lanes 9–16). Fifty nano-
grams of genomic DNA for each of the sample was electro-
phoresed on 1.0% agarose gels. M1 and M2 indicate lambda 
DNA digested with Hind III and 100-bp DNA ladder marker, 
respectively.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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over 99.8%. However, about 20% of a total of 909,622
SNPs were found to be monomorphic in the Japanese
population, which is due to SNP selection methods. The
SNPs assayed on the SNP Array 6.0 platform were mainly
selected as observed with high MAF in the Caucasian pop-
ulation. Among a total of 909,622 SNPs genotyped using
the SNP Array 6.0 platform with 184 Japanese samples,
590,248 SNPs passed three SNP filtering criteria; MAF >
5%, HWE p-value > 0.001 and SNP call rate > 95%.
Although the exact number of SNPs within the human
genome remains under discussion, it has been reported
that the genome coverage of the JPT + CHB population in
the Phase II HapMap data was 66% using the Mapping
500 K Array set [10]. The genome coverage of the SNP
array 6.0 platform was estimated using the same calcula-
tion and was revealed to be 75% with the 590,248 SNPs
in the Japanese population.
Conclusion
The current Affymetrix SNP Array 6.0 platform enables the
genotyping of over 900 K SNPs with high overall call rate
(over 99.5%) and high concordance rate (over 99.8%).
The number of SNPs available for GWAS in the Japanese
population was revealed to be over 660 K SNPs, all of
which passed the three SNP filtering criteria; MAF > 1%,
HWE p-value > 0.001 and SNP call rate > 95%. GWAS
Genotype calling accuracy with Birdseed algorithm Figure 5
Genotype calling accuracy with Birdseed algorithm. a-d. Genotype calls determined using 198 samples with over 86% 
QC criteria were used as a reference. The average overall call rate for the 4 sets of the 12 samples were determined with 7 
different sample sizes; 12 samples, 24 samples, 36 samples, 48 samples, 72 samples, 96 samples and 198 samples. The average 
concordance rates for the 4 sets of 12 samples were determined by comparison with the reference genotype calls. A negative 
correlation with a P value of 0.0053 and a positive correlation with a P value of 0.0115 were shown for overall call rate and 
concordance rate by fitting the power-law distribution to the data with least-squares approximation.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
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Removal of low-quality samples by adjusting QC criteria Figure 6
Removal of low-quality samples by adjusting QC criteria. Overall call rate for each sample was determined using total 
samples that passed the QC criteria. a. Overall call rate and QC call rate for each sample plotted with QC criteria > 86% and 
> 95%. b. Overall call rate (OCR) determined with 86% QC criteria compared with that determined with 95% QC criteria. c. 
Overall call rate (OCR) determined with 86% QC criteria compared with that determined using 184 samples.BMC Genomics 2008, 9:431 http://www.biomedcentral.com/1471-2164/9/431
Page 9 of 10
(page number not for citation purposes)
using the SNP Array 6.0 platform has considerable poten-
tial in identifying candidate susceptibility or resistance
genetic loci for multifactorial diseases in the Japanese
population, as well as in other populations.
Finally, the genotyping data of 400 Japanese samples
using the SNP array 6.0 platform will be deposited in a




Blood samples were obtained from two sets of 200 Japa-
nese individuals in two institutes. Genomic DNA was
extracted from peripheral blood leukocytes using the
QIAamp Blood Mini Kit (Qiagen) according to the manu-
facturer's instructions. All genomic DNA was resuspended
with Reduced EDTA TE Buffer (TEKnova) at 50 ng/μl. This
study was approved by the Research Ethics Committee of
the Faculty of Medicine, The University of Tokyo and
Tokai University. Informed consent was obtained from all
participants.
Genotyping 400 Japanese samples with SNP Array 6.0 
platform
The concentration of genomic DNA for all individuals was
measured using a spectrophotometer (NanoDrop ND-
1000, NanoDrop Technologies). For the 1st set of 200
samples, five samples had low genomic DNA concentra-
tions with an average of 41.1 ng/μl ranging from 38.2 to
44.5 ng/μl, and the remaining 195 samples had an aver-
age of 54.8 ng/μl, ranging from 45.0 to 57.8 ng/μl. For the
2nd set of 200 samples, one sample had 39.1 ng/μl and the
remaining 199 samples had an average of 52.7 ng/μl,
ranging from 45.0 to 55.9 ng/μl. For each individual
assayed, 250 ng of genomic DNA was digested with Sty I
and Nsp I (New England BioLabs) by adding 6 μl for the
6 samples with low concentration (five samples for 1st set
and one sample for 2nd set) and 5 μl for the remaining
samples. For two sets of 200 samples, every 48 samples
were simultaneously processed in a single 96-well plate.
After the reaction with restriction enzymes, we followed
the manufacturer's instructions for the Affymetrix
Genome-wide Human SNP array 6.0. The concentration
of PCR products after purification with magnetic beads
(Agencourt Magnetic Beads, Beckman) was measured
using a spectrophotometer (NanoDrop ND-1000). Puri-
fied PCR products were diluted 10-fold with TE buffer (pH
8.0) (WAKO) in order to have a suitable concentration for
the spectrophotometer to measure. The genotype calls of
each individual were determined by the Birdseed version
1 genotype calling algorithm, embedded in the software
Affymetrix Genotyping Console 2.0 (Affymetrix). The
number of samples used to determine the genotype calls
varied depending on the examination.
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